These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
243 related articles for article (PubMed ID: 35214169)
1. Design, Preparation and In Vitro Evaluation of Core-Shell Fused Deposition Modelling 3D-Printed Verapamil Hydrochloride Pulsatile Tablets. Li R; Pan Y; Chen D; Xu X; Yan G; Fan T Pharmaceutics; 2022 Feb; 14(2):. PubMed ID: 35214169 [TBL] [Abstract][Full Text] [Related]
2. Preparation and In vitro Evaluation of FDM 3D-Printed Ellipsoid-Shaped Gastric Floating Tablets with Low Infill Percentages. Chen D; Xu XY; Li R; Zang GA; Zhang Y; Wang MR; Xiong MF; Xu JR; Wang T; Fu H; Hu Q; Wu B; Yan GR; Fan TY AAPS PharmSciTech; 2019 Nov; 21(1):6. PubMed ID: 31754916 [TBL] [Abstract][Full Text] [Related]
3. Fabrication of timed-release indomethacin core-shell tablets for chronotherapeutic drug delivery using dual nozzle fused deposition modeling (FDM) 3D printing. Chung S; Zhang P; Repka MA Eur J Pharm Biopharm; 2023 Jul; 188():254-264. PubMed ID: 37201727 [TBL] [Abstract][Full Text] [Related]
4. Novel Gastroretentive Floating Pulsatile Drug Delivery System Produced via Hot-Melt Extrusion and Fused Deposition Modeling 3D Printing. Reddy Dumpa N; Bandari S; A Repka M Pharmaceutics; 2020 Jan; 12(1):. PubMed ID: 31936212 [TBL] [Abstract][Full Text] [Related]
5. Role of release modifiers to modulate drug release from fused deposition modelling (FDM) 3D printed tablets. Shi K; Salvage JP; Maniruzzaman M; Nokhodchi A Int J Pharm; 2021 Mar; 597():120315. PubMed ID: 33540000 [TBL] [Abstract][Full Text] [Related]
6. FDM 3D-Printed Sustained-Release Gastric-Floating Verapamil Hydrochloride Formulations with Cylinder, Capsule and Hemisphere Shapes, and Low Infill Percentage. Qian H; Chen D; Xu X; Li R; Yan G; Fan T Pharmaceutics; 2022 Jan; 14(2):. PubMed ID: 35214013 [TBL] [Abstract][Full Text] [Related]
7. [Preparation and Chen D; Xu XY; Wang MR; Li R; Zang GA; Zhang Y; Qian HN; Yan GR; Fan TY Beijing Da Xue Xue Bao Yi Xue Ban; 2021 Mar; 53(2):348-354. PubMed ID: 33879910 [TBL] [Abstract][Full Text] [Related]
8. Fabricating a Shell-Core Delayed Release Tablet Using Dual FDM 3D Printing for Patient-Centred Therapy. Okwuosa TC; Pereira BC; Arafat B; Cieszynska M; Isreb A; Alhnan MA Pharm Res; 2017 Feb; 34(2):427-437. PubMed ID: 27943014 [TBL] [Abstract][Full Text] [Related]
9. Fabrication of 3D-Printed Hydrocortisone Triple Pulsatile Tablet Using Fused Deposition Modelling Technology. Chen H; Zheng K; Bu T; Li X; Wang X; Pan H AAPS PharmSciTech; 2024 Mar; 25(3):58. PubMed ID: 38472689 [TBL] [Abstract][Full Text] [Related]
10. Impact of drug load and polymer molecular weight on the 3D microstructure of printed tablets. Larsen BS; Kissi E; Nogueira LP; Genina N; Tho I Eur J Pharm Sci; 2024 Jan; 192():106619. PubMed ID: 37866675 [TBL] [Abstract][Full Text] [Related]
11. 3D printing of pharmaceutical oral solid dosage forms by fused deposition: The enhancement of printability using plasticised HPMCAS. Oladeji S; Mohylyuk V; Jones DS; Andrews GP Int J Pharm; 2022 Mar; 616():121553. PubMed ID: 35131354 [TBL] [Abstract][Full Text] [Related]
12. A Lower Temperature FDM 3D Printing for the Manufacture of Patient-Specific Immediate Release Tablets. Okwuosa TC; Stefaniak D; Arafat B; Isreb A; Wan KW; Alhnan MA Pharm Res; 2016 Nov; 33(11):2704-12. PubMed ID: 27506424 [TBL] [Abstract][Full Text] [Related]
13. [Preparation and Kaidierya A; Zhang RG; Qian HN; Zou ZY; Danniya Y; Fan TY Beijing Da Xue Xue Bao Yi Xue Ban; 2022 Dec; 54(6):1202-1207. PubMed ID: 36533356 [TBL] [Abstract][Full Text] [Related]
14. Fabrication of extended-release patient-tailored prednisolone tablets via fused deposition modelling (FDM) 3D printing. Skowyra J; Pietrzak K; Alhnan MA Eur J Pharm Sci; 2015 Feb; 68():11-7. PubMed ID: 25460545 [TBL] [Abstract][Full Text] [Related]
15. Preparation and characterization of hot-melt extruded polycaprolactone-based filaments intended for 3D-printing of tablets. Viidik L; Vesala J; Laitinen R; Korhonen O; Ketolainen J; Aruväli J; Kirsimäe K; Kogermann K; Heinämäki J; Laidmäe I; Ervasti T Eur J Pharm Sci; 2021 Mar; 158():105619. PubMed ID: 33115676 [TBL] [Abstract][Full Text] [Related]
16. Development of multiple structured extended release tablets via hot melt extrusion and dual-nozzle fused deposition modeling 3D printing. Zhang P; Li J; Ashour EA; Chung S; Wang H; Vemula SK; Repka MA Int J Pharm; 2024 Mar; 653():123905. PubMed ID: 38355075 [TBL] [Abstract][Full Text] [Related]
17. Challenges, current status and emerging strategies in the development of rapidly dissolving FDM 3D-printed tablets: An overview and commentary. Serajuddin ATM ADMET DMPK; 2023; 11(1):33-55. PubMed ID: 36778904 [TBL] [Abstract][Full Text] [Related]
18. Structure-function correlation and personalized 3D printed tablets using a quality by design (QbD) approach. Zhang J; Thakkar R; Zhang Y; Maniruzzaman M Int J Pharm; 2020 Nov; 590():119945. PubMed ID: 33027633 [TBL] [Abstract][Full Text] [Related]
19. 3D Printed Intragastric Floating and Sustained-Release Tablets with Air Chambers. Zhao X; Wei W; Niu R; Li Q; Hu C; Jiang S J Pharm Sci; 2022 Jan; 111(1):116-123. PubMed ID: 34303671 [TBL] [Abstract][Full Text] [Related]
20. Tailoring amlodipine release from 3D printed tablets: Influence of infill patterns and wall thickness. Obeid S; Madžarević M; Ibrić S Int J Pharm; 2021 Dec; 610():121261. PubMed ID: 34742830 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]